Dawn Collier
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
-
- interferon and immune responses 3
- Co-authors
- Daniel Putensen (1 shared paper)
- Journals
- JAMA (6 papers)The Lancet (6 papers)Nature (4 papers)Journal of Clinical Apheresis (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- United KingdomAustraliaIndonesia
In The Last Decade
Dawn Collier
20 papers receiving 3.1k citations
Dawn Collier's Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 1.7k
- Neurology 559
- Applied Microbiology and Biotechnology 52
- Internal Medicine 87
- Critical Care and Intensive Care Medicine 120
Countries citing papers authored by Dawn Collier
This map shows the geographic impact of Dawn Collier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Collier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Collier more than expected).
Fields of papers citing papers by Dawn Collier
This network shows the impact of papers produced by Dawn Collier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Collier. The network helps show where Dawn Collier may publish in the future.
Co-authors
The 1 scholars most cited alongside Dawn Collier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 6 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 7 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 8 | 2021 | 163 | |
| 9 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 10 | 2022 | 104 | |
| 11 | 2022 | 99 | |
| 12 | 2023 | 83 | |
| 13 | 2021 | 70 | |
| 14 | 2023 | 62 | |
| 15 | 2023 | 56 | |
| 16 | 2023 | 45 | |
| 17 | 2023 | 34 | |
| 18 | 2015 | 18 | |
| 19 | 2024 | 8 | |
| 20 | 2025 | 1 |
About Dawn Collier
Dawn Collier is a scholar working on Infectious Diseases, Immunology, Epidemiology, Emergency Medical Services and Genetics, having authored 20 papers that have together received 3.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), interferon and immune responses (3 papers), Sepsis Diagnosis and Treatment (2 papers), Vitamin C and Antioxidants Research (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Respiratory viral infections research (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Neurology (559 citations), Applied Microbiology and Biotechnology (52 citations), Internal Medicine (87 citations) and Critical Care and Intensive Care Medicine (120 citations). Dawn Collier has collaborated with scholars based in United Kingdom, Australia and Indonesia. Frequent co-authors include Daniel Putensen. Their work appears in journals such as JAMA, The Lancet, Nature, Journal of Clinical Apheresis and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.